Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

[Transition Units].

Elías Pollina J, Martí Carrera E, Romero Otero J.

Cir Pediatr. 2018 Aug 3;31(3):105-106. Spanish. No abstract available.

PMID:
30260100
2.

[Correlation between symptoms and urodynamic results in patients with urinary incontinence after radical prostatectomy.]

Medina-Polo J, Arrébola-Pajares A, de la Rosa-Kehrmann S, Romero-Otero J, García-Gómez B, Alonso-Isa M, Lara-Isla A, Duarte-Ojeda JM, Rodríguez-Antolín A, Passas-Martínez JB.

Arch Esp Urol. 2018 Jul;71(6):523-530. Spanish.

PMID:
29991660
3.

The Brief Sexual Symptom Checklist as a Screening Tool for Sex-Related Problems in the Primary Care Setting: Focus on Erectile Dysfunction.

Romero Otero J, García Gómez B, Medina Polo J, García Rojo E, García Cruz E, Peinado F, Sopeña Sutil R, Bozzini G, Rodríguez Antolín A.

Urol Int. 2018;101(1):98-105. doi: 10.1159/000489014. Epub 2018 May 16.

PMID:
29768277
4.

Efficacy and safety of a hexanic extract of Serenoa repens (Permixon® ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies.

Vela-Navarrete R, Alcaraz A, Rodríguez-Antolín A, Miñana López B, Fernández-Gómez JM, Angulo JC, Castro Díaz D, Romero-Otero J, Brenes FJ, Carballido J, Molero García JM, Fernández-Pro Ledesma A, Cózar Olmos JM, Manasanch Dalmau J, Subirana Cachinero I, Herdman M, Ficarra V.

BJU Int. 2018 Apr 25. doi: 10.1111/bju.14362. [Epub ahead of print]

PMID:
29694707
5.

[Maximal androgen deprivation with abiraterone acetate in hormone sensitive prostate cancer.]

Rodríguez Antolín A, Romero Otero J, Duarte Ojeda J, García González L, Sopeña Sutil R, González Padilla D, García Rojo E, Justo Quintas J, Miñana López B.

Arch Esp Urol. 2018 Mar;71(3):267-275. Review. Spanish.

PMID:
29633947
6.

[Training program on medical urology: Future perspectives.]

Gil Moradillo J, Cabrera Meiras F, Alonso Isa M, Lara Isla A, Justo Quintas J, García Rojo E, González Padilla D, García Gómez B, Medina Polo J, Romero Otero J.

Arch Esp Urol. 2018 Jan;71(1):114-118. Spanish.

PMID:
29336340
7.

Grafts for Peyronie's disease: a comprehensive review.

Garcia-Gomez B, Ralph D, Levine L, Moncada-Iribarren I, Djinovic R, Albersen M, Garcia-Cruz E, Romero-Otero J.

Andrology. 2018 Jan;6(1):117-126. doi: 10.1111/andr.12421. Epub 2017 Dec 20. Review.

PMID:
29266877
8.

Surgical correction of Peyronie's disease via tunica albuginea plication: long-term follow-up.

Seveso M, Melegari S, De Francesco O, Macchi A, Romero Otero J, Taverna G, Bozzini G.

Andrology. 2018 Jan;6(1):47-52. doi: 10.1111/andr.12431. Epub 2017 Dec 1.

PMID:
29195031
9.

The digital environment in men's sexual disorders: A systematic review.

García-Cruz E, Romero-Otero J, Fode M, Alcaraz A.

Actas Urol Esp. 2017 Nov 1. pii: S0210-4806(17)30177-8. doi: 10.1016/j.acuro.2017.05.008. [Epub ahead of print] English, Spanish.

PMID:
29102483
10.

Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).

Rosen RC, Wu F, Behre HM, Porst H, Meuleman EJH, Maggi M, Romero-Otero J, Martinez-Salamanca JI, Jones TH, Debruyne FMJ, Kurth KH, Hackett GI, Quinton R, Stroberg P, Reisman Y, Pescatori ES, Morales A, Bassas L, Cruz N, Cunningham GR, Wheaton OA; RHYME Investigators.

J Sex Med. 2017 Sep;14(9):1104-1115. doi: 10.1016/j.jsxm.2017.07.004. Epub 2017 Aug 7.

PMID:
28781213
11.

Sexual Satisfaction: An Opportunity to Explore Overall Health in Men.

García-Gómez B, García-Cruz E, Bozzini G, Justo-Quintas J, García-Rojo E, Alonso-Isa M, Romero-Otero J.

Urology. 2017 Sep;107:149-154. doi: 10.1016/j.urology.2017.06.031. Epub 2017 Jun 29.

PMID:
28669747
12.

The Patient's Comorbidity Burden Correlates with the Erectile Dysfunction Severity.

García-Cruz E, Carrión A, Ajami T, Álvarez M, Correas MÁ, García B, García JV, González C, Portillo JA, Romero-Otero J, Simón C, Torremadé J, Vigués F, Alcaraz A.

Actas Urol Esp. 2018 Jan - Feb;42(1):57-63. doi: 10.1016/j.acuro.2017.03.011. Epub 2017 Jun 20. English, Spanish.

PMID:
28641871
13.

Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME).

Maggi M, Wu FC, Jones TH, Jackson G, Behre HM, Hackett G, Martin-Morales A, Balercia G, Dobs AS, Arver ST, Maggio M, Cunningham GR, Isidori AM, Quinton R, Wheaton OA, Siami FS, Rosen RC; RHYME Investigators.

Int J Clin Pract. 2016 Oct;70(10):843-852. doi: 10.1111/ijcp.12876.

PMID:
27774779
14.

Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.

Debruyne FM, Behre HM, Roehrborn CG, Maggi M, Wu FC, Schröder FH, Jones TH, Porst H, Hackett G, Wheaton OA, Martin-Morales A, Meuleman E, Cunningham GR, Divan HA, Rosen RC; RHYME Investigators.

BJU Int. 2017 Feb;119(2):216-224. doi: 10.1111/bju.13578. Epub 2016 Aug 14.

15.

Role of Penile Doppler US in the Preoperative Assessment of Penile Squamous Cell Carcinoma Patients: Results From a Large Prospective Multicenter European Study.

Bozzini G, Provenzano M, Romero Otero J, Margreiter M, Garcia Cruz E, Osmolorskij B, Verze P, Pavan N, Sanguedolce F, Buffi N, Ferrucio GG, Taverna G.

Urology. 2016 Apr;90:131-5. doi: 10.1016/j.urology.2016.01.003. Epub 2016 Jan 14.

PMID:
26776562
16.

Active surveillance for prostate cancer.

Romero-Otero J, García-Gómez B, Duarte-Ojeda JM, Rodríguez-Antolín A, Vilaseca A, Carlsson SV, Touijer KA.

Int J Urol. 2016 Mar;23(3):211-8. doi: 10.1111/iju.13016. Epub 2015 Nov 30. Review.

17.

Feasibility and safety of conservative surgery for the treatment of spermatic cord leiomyosarcoma.

Bozzini G, Albersen M, Romero Otero J, Margreiter M, Garcia Cruz E, Mueller A, Gratzke C, Serefoglu EC, Martinez Salamanca JI, Verze P.

Int J Surg. 2015 Dec;24(Pt A):81-4. doi: 10.1016/j.ijsu.2015.11.012. Epub 2015 Nov 11.

18.

Semen Quality Assessment in Fertile Men in Madrid During the Last 3 Decades.

Romero-Otero J, Medina-Polo J, García-Gómez B, Lora-Pablos D, Duarte-Ojeda JM, García-González L, García-Cruz E, Rodríguez-Antolín A.

Urology. 2015 Jun;85(6):1333-8. doi: 10.1016/j.urology.2015.02.001. Epub 2015 Apr 11.

PMID:
25872697
19.

Effects of tadalafil once daily or on demand versus placebo on time to recovery of erectile function in patients after bilateral nerve-sparing radical prostatectomy.

Moncada I, de Bethencourt FR, Lledó-García E, Romero-Otero J, Turbi C, Büttner H, Henneges C, Martinez Salamanca JI.

World J Urol. 2015 Jul;33(7):1031-8. doi: 10.1007/s00345-014-1377-3. Epub 2014 Aug 26.

20.

Marked testosterone deficiency-related symptoms may be associated to higher metabolic risk in men with low testosterone levels.

García-Cruz E, Leibar-Tamayo A, Romero-Otero J, Asiaín I, Carrión A, Castañeda R, Mateu L, Luque P, Cardeñosa O, Alcaraz A.

J Sex Med. 2014 Sep;11(9):2292-301. doi: 10.1111/jsm.12615. Epub 2014 Jun 26.

PMID:
24975551

Supplemental Content

Loading ...
Support Center